| Product NDC: | 50419-344 |
| Proprietary Name: | Ultravist |
| Non Proprietary Name: | iopromide |
| Active Ingredient(s): | 623.4 mg/mL & nbsp; iopromide |
| Administration Route(s): | INTRA-ARTERIAL |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50419-344 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021425 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091230 |
| Package NDC: | 50419-344-43 |
| Package Description: | 10 VIAL, GLASS in 1 CARTON (50419-344-43) > 100 mL in 1 VIAL, GLASS |
| NDC Code | 50419-344-43 |
| Proprietary Name | Ultravist |
| Package Description | 10 VIAL, GLASS in 1 CARTON (50419-344-43) > 100 mL in 1 VIAL, GLASS |
| Product NDC | 50419-344 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | iopromide |
| Dosage Form Name | INJECTION |
| Route Name | INTRA-ARTERIAL |
| Start Marketing Date | 20091230 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | IOPROMIDE |
| Strength Number | 623.4 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |